Neflamapimod endorsement based on targeted mechanism of action, demonstrated clinical activity in neurodegenerative diseases, and encouraging ...
Clinical Trials Arena on MSN
Cyrano reports positive data from phase II trial of CYR-064
The study met its primary objective, showing that CYR-064 was safe and well tolerated.
In a new study from Karolinska Institutet, published in Nature Neuroscience, researchers have identified the neurogenic ...
With the introduction of adaptive deep brain stimulation (aDBS) for Parkinson's disease, new questions emerge regarding who, why, and how to treat. This paper outlines the pathophysiological rationale ...
A team led by Northwestern University and Shirley Ryan AbilityLab scientists have developed a new technology that can eavesdrop on the hidden electrical dialogues unfolding inside miniature, lab-grown ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results